Prosecution Insights
Prosecution Insights
Technology areas: Transportation, E-Commerce & Mechanical Systems • Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Beacon Biosignals Inc. currently manages 2 pending office actions within the Transportation, E-Commerce & Mechanical Systems technology area. These matters are distributed across 2 distinct art units, which indicates a range of technical classifications for the company's pending intellectual property. The involvement of 2 distinct examiners suggests that the portfolio is not concentrated under a single individual's review, providing different perspectives on the 2 pending office actions.
The busiest examiner for the company is SIOZOPOULOS, CONSTANTINE B, who is responsible for 1 pending office action. This represents a portion of the 2 pending office actions currently active for the portfolio. Because the workload is split between 2 distinct examiners and 2 distinct art units, the prosecution strategy must account for different examiner styles and art unit norms. This distribution suggests that while the portfolio is small, it requires monitoring across multiple points of contact within the USPTO's Transportation, E-Commerce & Mechanical Systems sector.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (50%) |
| §101 + other | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SIOZOPOULOS, CONSTANTINE B | 1 | 58.0% | +38.8% |
| TOMBERS, JOSEPH A | 1 | 49.8% | +32.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18358333 | SYSTEM AND A METHOD FOR DETECTING AND QUANTIFYING ELECTROENCEPHALOGRAPHIC BIOMARKERS IN ALZHEIMER'S DISEASE | SIOZOPOULOS, CONSTANTINE B | 71d overdue |
| 17863803 | SYSTEMS AND METHODS FOR RAPID NEUROLOGICAL ASSESSMENT OF CLINICAL TRIAL PATIENTS | TOMBERS, JOSEPH A | 1d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18358333 | SYSTEM AND A METHOD FOR DETECTING AND QUANTIFYING ELECTROENCEPHALOGRAPHIC BIOMARKERS IN ALZHEIMER'S DISEASE | SIOZOPOULOS, CONSTANTINE B | 71d overdue |
| 17863803 | SYSTEMS AND METHODS FOR RAPID NEUROLOGICAL ASSESSMENT OF CLINICAL TRIAL PATIENTS | TOMBERS, JOSEPH A | 1d overdue |
| Art Unit | Apps |
|---|---|
| 3686 | 1 |
| 3791 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18358333 | SYSTEM AND A METHOD FOR DETECTING AND QUANTIFYING ELECTROENCEPHALOGRAPHIC BIOMARKERS IN ALZHEIMER'S DISEASE | SIOZOPOULOS, CONSTANTINE B | 3686 | §101 | Non-Final OA | 71d overdue | Pending | Jul 25, 2023 |
| 17863803 | SYSTEMS AND METHODS FOR RAPID NEUROLOGICAL ASSESSMENT OF CLINICAL TRIAL PATIENTS | TOMBERS, JOSEPH A | 3791 | §101§102 | Final Rejection | 1d overdue | Pending | Jul 13, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial